Inhibition of proliferation and apoptosis of human and rat T lymphocytes by curcumin, a curry pigment

Biochemical Pharmacology

Volumn 54, Issue 8, 1997, Pages 899-907

  Sikora, Ewa ^a   Bielak Zmijewska, Anna ^a   Piwocka, Katarzyna ^a   Skierski, Janusz ^b   Radziszewska, Ewa ^a  

^a NENCKI INSTITUTE OF EXPERIMENTAL BIOLOGY   (Poland)

^b NATIONAL MEDICINES INSTITUTE   (Poland)

Author keywords

AP 1; Apoptosis; Curcumin; Proliferation; T lymphocytes

Indexed keywords

CONCANAVALIN A; CURCUMIN; DEXAMETHASONE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; LEUKEMIA CELL LINE; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE; THYMOCYTE;

ANIMALS; APOPTOSIS; CELL DIVISION; CONCANAVALIN A; CURCUMIN; DEXAMETHASONE; DNA; DNA-BINDING PROTEINS; GLUCOCORTICOIDS; GROWTH INHIBITORS; HUMANS; LYMPHOCYTE ACTIVATION; RATS; RATS, WISTAR; T-LYMPHOCYTES; TRANSCRIPTION FACTOR AP-1; TUMOR CELLS, CULTURED;

EID: 0030882579     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)00251-7     Document Type: Article

References (48)

1. Huang MT, Wang ZY, Georgiadis CA, Laskin JD and Conney AH, Inhibitory effects of curcumin on tumor initiation by benzo[α]pyrene and 7,12-dimethylbenz[α]anthracene. Carcinogenesis 13: 2183-2186, 1992.
2. Huang MT, Smart RC, Wong CQ and Conney AH, Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res 48: 5941-5946, 1988.
3. Conney AH, Lysz T, Ferraro T, Abiddi TF, Manchand PS, Laskin JD and Huang MT, Inhibitory effect of curcumin and some related dietary compounds on tumor promotion and arachidonic acid metabolism in mouse skin. Adv Enzyme Regul 31: 385-396, 1991.
4. Huang MT, Lou YR, Ma W, Newmark HL, Reuhl KR and Conney AH, Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice. Cancer Res 54: 5841-5847, 1994.
5. Tanaka T, Makita H, Ohnishi M, Hirose Y, Wang A, Mori H, Satoh K, Hara A and Ogawa H, Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis by dietary curcumin and hesperidin: comparison with the protective effect of beta-carotene. Cancer Res 54: 4653-4659, 1994.
6. Rao-C, Rivenson A, Simi B and Reddy BS, Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. Cancer Res 55: 259-266, 1995.
7. Reddy AC and Lokesh BR, Studies on anti-inflammatory activity of spice principles and dietary n-3 polyunsaturated fatty acids on carrageenan-induced inflammation in rats. Ann Nutr Metab 1: 349-358, 1994.
8. Ammon HP, Safayhi H, Mack T and Sabieraj J, Mechanism of antiinflammatory actions of curcumin and boswellic acids. J Ethnopharmacol 38: 113-119, 1993.
9. Ruby AJ, Kuttan G, Babu KD, Rajasekhara KN and Kuttan R, Antitumour and antioxidant activity of natural curcuminoids. Cancer Lett 94: 79-83, 1995.
10. Sreejayan and Rao MN, Curcuminoids as potent inhibitors of lipid peroxidation. J Pharm Pharmacol 46: 1013-1016, 1994.
11. Rajakumar DV and Rao MN, Antioxidant properties of dehydrozingerone and curcumin in rat brain homogenates. Mol Cell Biochem 140: 73-79, 1994.
12. Reddy AC and Lokesh BR, Studies on the inhibitory effects of curcumin and eugenol on the formation of reactive oxygen species and the oxidation of ferrous iron. Mol Cell Biochem 137: 1-8, 1994.
13. Joe B and Lokesh BR, Role of capsaicin, curcumin and dietary n-3 fatty acids in lowering the generation of reactive oxygen species in rat peritoneal macrophages. Biochim Biophys Acta 1224: 255-263, 1994.
14. Kunchandy E and Rao MNA, Oxygen radical scavenging activity of curcumin. Int J Pharm 58: 237-240, 1990.
15. Subramanian M, Sreejayan, Rao MN, Devasagayam TP and Singh BB, Diminution of singlet oxygen-induced DNA damage by curcumin and related antioxidants. Mutat Res 311: 249-255, 1994.
16. Liu JY, Lin SJ and Lin JK, Inhibitory effects of curcumin on protein kinase C activity induced by 12-O-tetradecanoylphorbol-13-acetate in NIH 3T3 cells. Carcinogenesis 14: 857-861, 1993.
17. Reddy S and Aggarwal BB, Curcumin is a non-competitive and selective inhibitor of phosphorylase kinase. FEBS Lett 341: 19-22, 1994.
18. Korutla L, Cheung JY, Mendelsohn J and Kumar R, Inhibition of ligand-induced activation of epidermal growth factor receptor tyrosine phosphorylation by curcumin. Carcinogenesis 16: 1741-1745, 1995.
19. Lu YP, Chang RL, Lou Y, Huang MT, Newmark HL, Reuhl KR and Conney AH, Effect of curcumin on 12-O-tetradecanoylphorbol-13-acetate- and ultraviolet B light-induced expression of c-Jun and c-Fos in JB6 cells and in mouse epidermis. Carcinogenesis 15: 2563-2370, 1994.
20. Kakar SS and Roy D, Curcumin inhibits TPA induced expression of c-fos, c-jun and c-myc proto-oncogene messenger RNAs in mouse skin. Cancer Lett 87: 85-89, 1994.
21. Huang TZ, Lee SC and Lin JK, Suppression of c-Jun/AP-1 activation by an inhibitor of tumor promotion in mouse fibroblast cells. Proc Natl Acad Sci USA 88: 5292-5296, 1991.
22. Takeshita A, Chen Y, Watanabe A, Kitano S and Hanazawa S, TGF-beta induces expression of monocyte chemoattractant JE/monocyte chemoattractant protein 1 via transcriptional factor AP-1 induced by protein kinase in osteoblastic cells. J Immunol 155: 419-426, 1995.
23. Singh S and Aggarwal BB, Activation of transcription factor NF-KB is suppressed by curcumin (diferulolylmethane). J Biol Chem 270: 24995-25000, 1995.
24. King KL and Cidlowski JA, Cell cycle and apoptosis: common pathways to life and death. J Cell Biochem 58: 175-180, 1995.
25. Buttyan R, Zakeri Z, Lockshin R and Wolgemuth D, Cascade induction of c-fos, c-myc, and heat shock 70K transcripts during regression of the rat ventral prostate gland. Mol Endocrinol 2: 650-657, 1988.
26. Colotta F, Polentarutti N, Sironi M and Mantovani A, Expression and involvement of c-fos and c-jun protooncogenes in programmed cell death induced by growth factor deprivation in lymphoid cell lines. J Biol Chem 267: 18278-18283, 1992.
27. Pandey S and Wang E, Cells en route to apoptosis are characterized by the upregulation of c-fos, c-myc, c-jun, cdc2, and RB phosphorylation, resembling events of early cell-cycle traverse. J Cell Biochem 58: 135-150, 1995.
28. Grassilli E, Carcereri de Prati A, Monti D, Troiano L, Menegazzi M, Barbieri D, Franceschi C and Suzuki H, Studies of the relationship between cell proliferation and cell death: early gene expression during concanavalin A-induced proliferation or dexamethasone-induced apoptosis of rat thymocytes. Biochem Biophys Res Commun 188: 1261-1266, 1992.
29. Sikora E, Grassilli E, Bellesia E, Troiano L and Franceschi C, Studies of the relationship between cell proliferation and cell death: AP-1 DNA-binding activity during concanavalin A-induced proliferation or dexamethasone-induced apoptosis of rat thymocytes. Biochem Biophys Res Commun 192: 386-391, 1993.
30. Sikora E, Grassilli E, Radziszewska E, Bellesia E, Barbieri D and Franceschi C, Transcription factors DNA-binding activity in rat thymocytes undergoing apoptosis after heat-shock or dexamethasone treatment. Biochem Biophys Res Commun 197: 709-715, 1993.
31. Marti A, Jehn B, Costello E, Keon N, Ke G, Martin F and Jaggi R, Protein kinase A and AP-1 (c-Fos/JunD) are induced during apoptosis of mouse mammary epithelial cells. Oncogene 9: 1213-1223, 1994.
32. Mosieniak G, Figiel I and Kaminska B, Cyclosporin A, an immunosuppresive drug, induces programmed cell death in rat C6 glioma cells by a mechanism that involves the AP-1 transcription factor. J Neurochem 68: 1142-1149, 1997.
33. Kim R and Beck WT, Differences between drug-sensitive and-resistant human leucemic CEM cells in c-jun expression, AP-1 DNA-binding activity, and formation of Jun/Fos family dimers, and their association with internucleosomal DNA ladders after treatment with VM-26. Cancer Res 54: 4958-4966, 1994.
34. Mollinedo F, Gajate C and Modolell M, The ether lipid 1-octadecyl-2-methyl-rac-glycero-3-phosphocholine induces expression of fos and jun proto-oncogenes and activates AP-1 transcription factor in human leukaemic cells. Biochem J 302: 325-329, 1994.
35. Ham J, Babij C, Whitfield J, Pfarr CM, Lallemand D, Yaniv M and Rubin LL, A c-Jun dominant negative mutant protects sympathetic neurons against programmed cell death. Neuron 14: 927-939, 1995.
36. Tong L and Perez P Jr, Transcription factor DNA binding activity in PC12 cells undergoing apoptosis after glucose deprivation. Neurosci Lett 191: 137-140, 1995.
37. Darzynkiewicz Z, Li-X and Gong J, Assays of cell viability: discrimination of cells dying by apoptosis. Methods Cell Biol 41: 15-38, 1994.
38. Smith CA, Gwyn TW, Kingston R, Jenkinson EJ and Owen JJT, Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature 337: 181-184, 1989.
39. Del Bino G, Skierski JS and Darzynkiewicz Z, The concentration-dependent diversity of effects of DNA topoisomerase I and II inhibitors on the cell cycle of HL-60 cells. Exp Cell Res 195: 485-491, 1991.
40. Gong J, Traganos F and Darzynkiewicz Z, A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry. Anal Biochem 218: 314-319, 1994.
41. Bradford MM, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
42. Zamani L, Falcieri E, Marhefka G and Vitale M, Supravital exposure to propidium iodide identifies apoptotic cells in the absence of nucleosomal DNA fragmentation. Cytometry 23: 303-311, 1996.
43. Sawai H, Okazaki T, Yamamoto H, Okano H, Takeda Y, Tashima M, Sawada H, Okuma M, Ishikura H, Umehara H et al., Requirement of AP-1 for ceramide-induced apoptosis in human leukemia HL-60 cells. J Biol Chem 270: 27326-27331, 1995.
44. Kroemer G, Petit P, Zamzani N, Vayssiere JL and Miggnote B, The biochemistry of programmed cell death. FASEB J 9: 1277-1287, 1995.
45. Lynn W and Wong PK, Neuroimmunodegeneration: do neurons and T cells use common pathways for cell death? FASEB J 9: 1147-1156, 1995.
46. Schulze-Ostroff K, Los M and Baeuerle P, Redox signalling by transcription factors NPKB and AP-1 in lymphocytes. Biochem Pharmacol 50: 735-741, 1995.
47. Li CJ, Zhang LJ, Dezube BJ, Crumpacker CS and Pardee AB, Three inhibitors of type 1 human immunodeficiency virus long terminal repeat-directed gene expression and virus replication. Proc Natl Acad Sci USA 90: 1839-1842, 1993.
48. Mazumder A, Raghavan K, Weinstein J, Kohn KW and Pommier Y, Inhibition of human immunodeficiency virus type-1 integrase by curcumin. Biochem Pharmacol 49: 1165-1170, 1995.